PAS
IONS icon

Park Avenue Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Park Avenue Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
+3,677
New +$277K ﹤0.01% 1539
2026
Q1 		– Sell
-3,571
Closed -$283K – 1610
2025
Q4 		$283K Buy
+3,571
New +$269K ﹤0.01% 1338

Other funds holding IONS

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Park Avenue Securities's IONS Position: Q2 2026 in Review

Park Avenue Securities opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 3,677 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in IONS as recently as Q4 2025.

Park Avenue Securities first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Park Avenue Securities held 3,677 shares of Ionis Pharmaceuticals worth $292K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Park Avenue Securities position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1539 holding.
  • Park Avenue Securities first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.